Arruebo, Manuel
Universidad de Zaragoza,
Spain
2025 Rank: 63048
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 758 out of 156020 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 63048 | 66743 |
| Total Cites | 8691 | 9545 |
| H-index | 45 | 49 |
| Hm-index | 16 | 18 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 184 | 184 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 3157 | 3207 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 3713 | 3890 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8241 | 8683 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.10 |
| Self-Citation Percentage |
8.95%
|
|
Arruebo, Manuel
Consejo Superior de Investigaciones Científicas,
Spain
2024 Rank: 64736
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 701 out of 135958 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64736 | 69642 |
| Total Cites | 7773 | 8577 |
| H-index | 43 | 47 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 164 | 164 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 2976 | 3032 |
| Number of Single+First+Last Authored Papers | 49 | 49 |
| Total Cites to Single+First+Last Authored Papers | 3405 | 3579 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7364 | 7777 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.10 |
| Self-Citation Percentage |
9.37%
|
|
Arruebo, Manuel
Universidad de Zaragoza,
Spain
2023 Rank: 66542
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 675 out of 117692 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 66542 | 72997 |
| Total Cites | 6853 | 7582 |
| H-index | 42 | 44 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 149 | 149 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 2765 | 2820 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 3098 | 3257 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6482 | 6863 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.10 |
| Self-Citation Percentage |
9.61%
|
|
Arruebo, Manuel
Universidad de Zaragoza,
Spain
2022 Rank: 74715
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 700 out of 103235 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74715 | 80655 |
| Total Cites | 5754 | 6359 |
| H-index | 37 | 41 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 132 | 132 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 2445 | 2498 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 2685 | 2805 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5461 | 5802 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.10 |
| Self-Citation Percentage |
9.51%
|
|
Arruebo, Manuel
Universidad de Zaragoza,
Spain
2021 Rank: 74224
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 655 out of 89177 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74224 | 80765 |
| Total Cites | 5375 | 5955 |
| H-index | 37 | 41 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 127 | 127 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 2306 | 2360 |
| Number of Single+First+Last Authored Papers | 38 | 38 |
| Total Cites to Single+First+Last Authored Papers | 2526 | 2639 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5097 | 5424 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.10 |
| Self-Citation Percentage |
9.74%
|
|
Arruebo, Manuel
Universidad de Zaragoza,
Spain
2020 Rank: 87544
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 739 out of 75210 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 87544 | 94784 |
| Total Cites | 4230 | 4714 |
| H-index | 32 | 35 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 109 | 109 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 1954 | 2006 |
| Number of Single+First+Last Authored Papers | 34 | 34 |
| Total Cites to Single+First+Last Authored Papers | 2072 | 2165 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4019 | 4294 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.10 |
| Self-Citation Percentage |
10.27%
|
|